Document Actions
2009 programme
| 0810-0910 | REGISTRATION AND REFRESHMENTS |
| 0910-0920 | Welcome and introduction by the Chair Dr Drew Provan Senior Lecturer in Haematology, Barts & The London School of Medicine & Dentistry, London, and Editor, ABC of Clinical Haematology |
| 0920-1005 | Myeloproliferative disorders This session will present an update on the management of myeloproliferative disorders. The speaker will cover:
Head of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge |
| 1005-1050 | Myeloma The speaker will discuss updates in the management of patients with multiple myeloma, including:
Consultant Haematologist, Royal United Hospital, Bath |
| 1050-1110 | REFRESHMENTS |
| 1110-1155 | Lymphoma This session will outline the major advances that have been made in the management of lymphomas over the past five years, with regard to the development of immunochemotherapy and prognostic stratification and response monitoring, particularly with CT and PET scanning. The speaker will highlight how these advances are making individualised therapy a realistic prospect. Dr Robert Marcus Consultant Haematologist, King's College Hospital, London |
| 1155-1240 | Myelodysplastic syndromes The speaker will discuss recent advances in the management of myelodysplastic syndromes, with particular emphasis on:
Professor of Haemato-oncology and Head of Department, King’s College Hospital, King’s College, London |
| 1240-1340 | LUNCH |
| 1340-1425 | Industry symposium sponsored by Roche
Management of chronic lymphocytic leukaemia – the present and the future in the antibody era This symposium will cover the evolution of treatment options in chronic lymphocytic leukaemia, including the use of the new therapeutic modalities available now and those likely to be used in the future. Emerging new data, first released at the American Society of Hematology annual meeting will also be presented and the speaker will argue the question: “Is rituximab in combination with chemotherapy the new standard of care in chronic lymphocytic leukaemia?” Dr George Follows Consultant Haematologist, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Dr Adrian Bloor Consultant Haematologist, The Christie Hospital, Manchester |
| 1425-1510 | Anaemia – recent advances in diagnosis and treatment The speaker will cover recent advances in the management of anaemias with particular emphasis on:
Consultant Haematologist, Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London |
| 1510-1530 | REFRESHMENTS |
| 1530-1615 | Thrombosis and bleeding This session will help you make decisions based on up to date evidence regarding:
Consultant Haematologist, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge |
| 1615-1700 | Haematological emergencies The speaker will cover important issues regarding key haematological emergencies including:
Consultant Haematologist, University Hospital Birmingham, Queen Elizabeth Medical Centre, Birmingham |
| 1700-1710 | SUMMARY AND CLOSING REMARKS |
PROGRAMME SUBJECT TO CHANGE
ALL CONTENT HAS BEEN REVIEWED BY THE EDITOR
